Brazil signs agreement to expand immunoglobulin supplies
The Hemobrás–Tiantan Bio cooperation covers supply of the plasma-derived medicine and prospective technology transfer.
Event / data period: 2026-10-02
Published: · Updated:
Brazil’s Health Ministry said Hemobrás and China’s Tiantan Bio signed a cooperation agreement in São Paulo on October 2 to broaden immunoglobulin supply sources. The ministry said the agreement sets a framework for registration in Brazil, supply of intravenous human immunoglobulin, and technology licensing and transfer.
Supply and technology details will be defined in separate agreements and remain subject to Anvisa requirements. The ministry also said equipment upgrades are expected to raise plasma-storage capacity by about 30%, 604 pieces of equipment were distributed to 125 hemotherapy services, and 38 million reais was allocated to improve blood-center services.
Data
Blood-center investment and capacity
Outcomes and allocations stated in the Health Ministry’s October 2 notice.
- Capacity increase expected
- ≈30 %
- 2026-10-02 · Estimate
- Blood-center service funding allocated
- 38 million BRL
- 2026-10-02 · Observed
- Equipment distributed
- 604 count
- 2026-10-02 · Observed
- Services receiving equipment
- 125 count
- 2026-10-02 · Observed
Methodology
The approximate 30% is expected capacity; funding, equipment and service coverage are administrative totals reported by the ministry.
Updated:
Subjects and places
Subject proposals
- Science and technologySuggested
- Subject suggested from the title or summary: technologywww.gov.br ↗
- HealthSuggested
- Preserved editorial category/topic; broad candidate onlywww.gov.br ↗
Geographic references
Only source-provided geographic references are shown. Opening an external map is optional. Optional story maps use OpenStreetMap. Opening a map sends your IP address and this site’s address to the map provider; location data remains readable as text without loading the map.
- Brazil · Place role: Coverage · Place type: Country or area · Location precision: RegionalEvidence
- Explicit preserved editorial country/region; no city or national centroid inferredwww.gov.br ↗